Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT07584304
PHASE1
Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects
Sponsor: Yuhan Corporation
View on ClinicalTrials.gov
Summary
An open-label, randomized, fasting, single-dose, oral administration, 2-sequence, 4-period, replicate crossover study to evaluate bioequivalence between YHP2508C and YHR2603 in healthy subjects
Official title: An Open-label, Randomized, Fasting, Single-dose, Oral Administration, 2-sequence, 4-period, Replicate Crossover Study to Evaluate Bioequivalence Between YHP2508C and YHR2603 in Healthy Subjects
Key Details
Gender
All
Age Range
19 Years - 54 Years
Study Type
INTERVENTIONAL
Enrollment
46
Start Date
2026-07-10
Completion Date
2026-09-23
Last Updated
2026-10-01
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
YHP2508C
Test drug
DRUG
YHR2603
Comparator drug
Locations (1)
Gimpo Woori Hospital
Gimpo-si, Gyeonggi-do, South Korea